- Phlebotomus papatasi exposure cross-protects mice against Leishmania major co-inoculated with Phlebotomus duboscqi salivary gland homogenate2015 | Faculty of Science
- Protective and cross-protective mucosal immunization of mice by inactivated influenza virus type A using Bacillus firmus as adjuvantPublication without faculty affiliation
- Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant2008 | First Faculty of Medicine
- Stimulation of Protective and Cross-Protective Immunity against Influenza B Virus after Adjuvant Mucosal Immunization of Mice2009 | First Faculty of Medicine
- Bacterial adjuvant for mucosal immunization of mice against influenza A virus; intersubtypic cross-protectionPublication without faculty affiliation
- Vaccination against HPV - what we did not know 8 years ago?2014 | First Faculty of Medicine
- Protection of mice against influenza A and B virus infection by mucosal immunization with Bacillus firmus as an adjuvant2011 | First Faculty of Medicine
- Three years of HPV vaccination by quadrivalent vaccine.2010 | First Faculty of Medicine
- Current aproach to HPV vaccination - - which are going in the new recommendations.2009 | Publication without faculty affiliation
- Vaccination against HPV infection – gynecologist's point of view2012 | First Faculty of Medicine
- Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus2013 | First Faculty of Medicine
- Adjuvant effect of Bacillus firmus on the expression of cytokines and toll-like receptors in mouse nasopharynx-associated lymphoid tissue (NALT) after intranasal immunization with inactivated influenza virus type A2010 | First Faculty of Medicine, Third Faculty of Medicine
- Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths2014 | First Faculty of Medicine